Three-week effect of amisulpride, aripiprazole, and olanzapine on gene expression in peripheral blood in individuals with schizophrenia spectrum disorders.

Saved in:
Bibliographic Details
Title: Three-week effect of amisulpride, aripiprazole, and olanzapine on gene expression in peripheral blood in individuals with schizophrenia spectrum disorders.
Authors: Torsvik A; Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.; Mohn Research Center for Psychotic Disorders (MRCP), Haukeland University Hospital, Bergen, Norway., Trentani A; Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway., Stokowy TK; Department of Clinical Science, University of Bergen, Bergen, Norway.; Interdisciplinary Pomeranian Centre for Digital Medicine, Medical University of Gdansk, 80-210 Gdansk, Poland., Skrede S; Department of Clinical Science, University of Bergen, Bergen, Norway.; Mohn Research Center for Psychotic Disorders (MRCP), Haukeland University Hospital, Bergen, Norway.; Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway., Joa I; TIPS - Network for Clinical Research in Psychosis, Stavanger University Hospital, Stavanger, Norway.; Department of Public Health, Faculty of Health, University of Stavanger, Stavanger, Norway., Klæbo Reitan SM; Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Mental Health, Nidelv DPS, St. Olavs Hospital, Trondheim, Norway., Rettenbacher M; Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University Innsbruck, Innsbruck, Austria., Kroken RA; Mohn Research Center for Psychotic Disorders (MRCP), Haukeland University Hospital, Bergen, Norway.; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway., Johnsen E; Mohn Research Center for Psychotic Disorders (MRCP), Haukeland University Hospital, Bergen, Norway.; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway., Steen VM; Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.; Mohn Research Center for Psychotic Disorders (MRCP), Haukeland University Hospital, Bergen, Norway.
Source: The international journal of neuropsychopharmacology [Int J Neuropsychopharmacol] 2026 Jun 02; Vol. 29 (6).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9815893 Publication Model: Print Cited Medium: Internet ISSN: 1469-5111 (Electronic) Linking ISSN: 14611457 NLM ISO Abbreviation: Int J Neuropsychopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1469-5111
DOI:10.1093/ijnp/pyag019